Adding the PI3-kinase inhibitor pictilisib to fulvestrant doubled progression-free survival for some women with advanced hormone-receptor positive breast cancer,...
After making great strides for some patients with melanoma and lung cancer, immunotherapy drugs are starting to offer hope...
SABCS co-chair and AACR President Carlos L. Arteaga, MD, shares his views on this year's symposium and what the...
Guest Post by T.J. Sharpe Originally appeared on Philly.com's Patient #1 blog
Nina Bhardwaj, MD, PhD, co-chair of the AACR's special conference "Tumor Immunology and Immunotherapy: A New Chapter," discusses what...
The National Cancer Institute’s Lee Helman, MD, co-chair of the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, discusses...
Research has fueled significant progress against breast cancer—the overall five-year survival rate for female breast cancer patients in the...
Cancer research has led to great progress in cancer prevention, detection, diagnosis, and treatment, improving and saving countless lives....
From Oct. 9-12, the American Association for Cancer Research will host its first major conference in China: New Horizons...
If you are someone who would bet all your chips on helping people not get cancer in the first...